Brief: Altamira Therapeutics Announces Collaboration With Heqet Therapeutics On Nanoparticle-Delivered Non-Coding RNAs For Cardiac Regeneration
05/07/2023 13:50
July 5 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS ANNOUNCES COLLABORATION WITH HEQET
THERAPEUTICS ON NANOPARTICLE-DELIVERED NON-CODING RNAS FOR
CARDIAC REGENERATION
* ALTAMIRA THERAPEUTICS: HEQET WILL TEST NANOPARTICLES BASED
ON
ALTAMIRA'S OLIGOPHORE DELIVERY PLATFORM IN REGENERATION OF
DAMAGED HEART TISSUE
* ALTAMIRA THERAPEUTICS: HEQET WILL, UNDER SOME CONDITIONS,
HAVE
OPTION TO NEGOTIATE WITH CO FOR LICENSE TO USE CO'S TECHNOLOGY,
INTELLECTUAL PROPERTY
Source text for Eikon: ID:nGNX7tp6TY
Further company coverage: CYTO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering